Centauri Therapeutics strengthens senior leadership team with three key appointments
Centauri Therapeutics Limited (Centauri), an immunotherapy company focused on the treatment of infectious diseases, today announced three senior appointments: Dr Jennifer Schneider as Chief Executive Officer (CEO), Dr Helen Bright as Vice President (VP) of Research & Development (R&D), and Professor David Roblin FRCP FMedSci as Chair of the Board of Directors.
Anthias Consulting courses at heart of analytical chemistry training in Africa
In June 2022, Anthias Consulting's training course materials were used to deliver a week-long practical based LC-MS workshop at the Kwame Nkrumah University of Science and Technology (KNUST) in Ghana.
Breakfast or Hotel Bar?
WaveFX says: So, after two years adapting to virtual and hybrid events from the studio and breakfast bar we’re happily back on the road. This week the WaveFX stream team produced and filmed webcasts and live events from conference hotels and venues across the UK, Sweden and Greece.
5 things every electrical medical device start-up should know
You’ve got a great idea for an electrical medical device, whether that’s a connected injector, point of care diagnostics device, a wearable device, or another innovative, life-changing device concept. You’ve identified a market for it, gained access to sector insights, you’ve tested the principles and are getting good results. All you need now is to engineer it into a real medical device product…
First genetic map of one of humans oldest parasites
The largest genomic analysis of the whipworm Trichuris trichiura has been published, giving the most in-depth evolutionary insight about this human parasite to date.
What you need to know when hiring workers from abroad
Has recruitment for your business got you thinking about hiring workers from overseas? There are a few things you need to know to ensure you remain compliant with employment law. We explore this topic further in our latest blog.
Hospital’s green bus service is just the ticket for patients and planet
Cambridge University Hospitals (CUH) has launched an environmentally friendly patient courtesy bus service, thanks to a team effort by ACT and a well-known patient governor.
Charity’s first Newmarket Race Day raises more than £40,000 to fund a psychologist for children with brain tumours
A children’s charity’s first ever race day at Newmarket Racecourse has raised more than £40,000 to fund a psychologist for families faced with a brain tumour.
Prologis starts construction on speculative life science development at Cambridge Biomedical Campus
Work has started on the first wholly speculative development of new multi-let laboratory and office space at Cambridge Biomedical Campus, which is specifically targeting a range of growing biotech and life science businesses.
AstraZeneca to acquire TeneoTwo and its clinical-stage T-cell engager, strengthening its haematological cancer pipeline
AstraZeneca announces an agreement to acquire TeneoTwo, Inc., including its Phase I clinical-stage CD19/CD3 T-cell engager, TNB-486, currently under evaluation in relapsed and refractory B-cell non-Hodgkin lymphoma1.
£900m investment to create one of Europe’s largest life sciences hubs in Stevenage
Stevenage Bioscience Catalyst - developer named for campus expansion.
Ubiquigent appoints Professor Helen Walden and Professor John Davis to Scientific Advisory Board
Experts in structural biology and drug development will help exploit the deubiquitylase (DUB) enzyme family as new drug targets
Mogrify and Astellas announce collaboration to conduct research on in vivo regenerative medicine approaches to address sensorineural hearing loss
Mogrify Limited, a biopharmaceutical company transforming the lives of patients through a novel class of in vivo reprogramming therapies, and Astellas Pharma Inc., a leader in regenerative medicine, today announced that they have executed a collaborative research agreement on in vivo regenerative medicine approaches to address sensorineural hearing loss.
Deloitte appoints new senior partner for the South East region covering Cambridge, St Albans and Ipswich
Deloitte has appointed Fran Cousins as the new senior partner for the South East region - the first woman to hold this senior position in the region.
Guardtech Group support Ugandan COVID battle with CleanCube mobile lab donation
Suffolk-based cleanroom construction company gifts £50,000 laboratory van for critical PCR testing
Arecor announces presentation at EASD 2022 of Phase I clinical trial of AT278 ultra-concentrated ultra-rapid acting insulin for diabetes
Arecor Therapeutics plc, a globally focused biopharmaceutical company advancing today’s therapies to enable healthier lives, announces that its abstract titled “Phase I study investigating PK and PD of highly-concentrated insulin aspart AT278 U500” has been selected for presentation as part of the Short Oral Discussion Session A at the 58th Annual Meeting of the European Association for the Study…
Opportunities in China’s beauty value economy
What are the drivers for the phenomenal growth in China's hair care, anti-aging, and aesthetic medicine and cosmetic surgery markets?
eg technology renew sponsorship of 2022 EIT Health Catapult
eg technology are pleased to announce they have renewed their sponsorship of the coveted EIT Health Catapult, in association with EIT Health.
Change Management doesn’t change the one thing you most need to change
High Performance Change says: If you wanted to drive across Australia, you’d pack the vehicle with a survival kit – to help you adapt to any situation you might find yourself in – before you departed. It would be utter madness to even think about just setting off as if it were a normal trip, armed only with the idea of dealing with stuff as it happens along the way. And yet, if the only way you…
LG Chem renews license triggering payment to Avacta
LG Chem will now proceed with Investigational New Drug (IND) enabling studies for Affimer PD-L1 antagonist programme
Biocair expands its European network with a new Paris operational hub
Experts in logistics for the healthcare industry for more than 35 years, Biocair continues to expand in response to the growing demand from European players in the biotech and healthcare sectors.
Charity Shop Manager shares her story
Arthur Rank Hospice Charity Shop Manager, Billie, shares her personal story ahead of the Chariots of Fire Repay Race in Cambridge 2022
Avacta announces second dose escalation in the Phase I clinical study of AVA6000 Pro-doxorubicin
Avacta Group plc (AIM: AVCT), a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative Affimer® and pre|CISION™ platforms, announces that the first-in-human Phase I trial (ALS-6000-101) of AVA6000 Pro-doxorubicin will advance to the third dose cohort following a positive review of the safety data from the dosing of the second cohort.
Cambridge study shapes advice on brain surgery
A body dedicated improving outcomes for victims of traumatic brain injury has updated guidelines for clinicians following latest findings from a Cambridge-led trial.
Bio-Rad launches EconoFit Chromatography Column Packs
HERCULES, Calif.— Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, announces the launch of EconoFit Low-Pressure Prepacked Chromatography Column Packs to support resin screening experiments in the development of protein purification workflows.